Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-Xi Chang
Single Nucleotide Polymorphisms of Casitas B-Lineage Lymphoma Proto-Oncogene-B Predict Outcomes of Patients With Advanced Non-Small Cell Lung Cancer After First-Line Platinum Based Doublet Chemotherapy
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Related publications
XPG Polymorphisms Are Associated With Prognosis of Advanced Non-Small Cell Lung Cancer Treated With Platinum-Based Doublet Chemotherapy
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Association Between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated With Chemotherapy
PLoS ONE
Multidisciplinary
Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Gene Expression and Single Nucleotide Polymorphism of ATP7B Are Associated With Platinum-Based Chemotherapy Response in Non-Small Cell Lung Cancer Patients
Journal of Cancer
Oncology
155P: PD-L1 Polymorphism Can Predict Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated With First-Line Paclitaxel–cisplatin Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy
BMJ Open
Medicine
Rechallenge With First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer
Case Reports in Oncology
Oncology
Circulating Nucleosomes Predict the Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
